Show simple item record

dc.creatorSavulescu, J.en
dc.creatorFoddy, B.en
dc.creatorClayton, M.en
dc.date.accessioned2016-01-08T23:47:43Zen
dc.date.available2016-01-08T23:47:43Zen
dc.date.created2004-12-01en
dc.date.issued2004-12-01en
dc.identifierdoi:10.1136/bjsm.2003.005249en
dc.identifier.bibliographicCitationBritish Journal of Sports Medicine 2004 December 1; 38(6): 666-670en
dc.identifier.urihttp://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Why+we+should+allow+performance+enhancing+drugs+in+sport&title=British+Journal+of+Sports+Medicine+&volume=38&issue=6&spage=666-670&date=2004-12&au=Savulescu,+J.;+Foddy,+B.;+Clayton,+M.en
dc.identifier.urihttp://dx.doi.org/10.1136/bjsm.2003.005249en
dc.identifier.urihttp://hdl.handle.net/10822/986244en
dc.formatArticleen
dc.languageenen
dc.sourceeweb:278516en
dc.subjectDrugsen
dc.subject.classificationDrugs and Drug Industryen
dc.subject.classificationHealth Care for Particular Diseases or Groupsen
dc.titleWhy We Should Allow Performance Enhancing Drugs in Sporten
dc.provenanceCitation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.en
dc.provenanceCitation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.en


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2022 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885